Robert Kerrey

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Auris Health, Inc. develops robotics technology for medical applications. The company was founded by Frederic H. Moll, Hariharan Sundram and Christopher J. P. Velis and is headquartered in Redwood City, CA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Vortex Control Technologies LLC develops technology based products for aircraft control and safety. Its products include finlets and eaglets. The company is headquartered in Kennesaw, GA.

Vortex Control Technologies LLC develops technology based products for aircraft control and safety. Its products include finlets and eaglets. The company is headquartered in Kennesaw, GA.

Vortex Control Technologies LLC develops technology based products for aircraft control and safety. Its products include finlets and eaglets. The company is headquartered in Kennesaw, GA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Vortex Control Technologies LLC develops technology based products for aircraft control and safety. Its products include finlets and eaglets. The company is headquartered in Kennesaw, GA.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Threat Deterrence Capital LLC operates as a holding company with interests in providing operational support, consulting, training, and engineering solutions. The company was founded on August 11, 2015 and is headquartered in Arlington, VA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Auris Health, Inc. develops robotics technology for medical applications. The company was founded by Frederic H. Moll, Hariharan Sundram and Christopher J. P. Velis and is headquartered in Redwood City, CA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Vortex Control Technologies LLC develops technology based products for aircraft control and safety. Its products include finlets and eaglets. The company is headquartered in Kennesaw, GA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

Monolith Materials, Inc. operates as a carbon black manufacturing company. The firm converts natural gas to carbon black. It produces hydrogen tail-gas, supplied to the power generation and industrial gas markets. The company was founded by Peter L. Johnson, Robert Hanson, and William J. Brady Jr. in 2012 and is headquartered in Lincoln, NE.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.